Partner Laura Ganoza was quoted in an article in The Washington Post, “The Battle Over a $52 Sports Bra Goes to Court,” which covered the patent and trademark infringement case that Lululemon Athletica has brought against Under Armour over a strappy sports bra against the backdrop of a $1 billion market share for the apparel.
Ganoza explained that these kinds of lawsuits are rare in the fashion industry as few retailers are willing to go through the trouble — or expense — of securing design patents for their products. She also explained that “this is a long, expensive process — we’re talking at least a year and half, and several thousand dollars — just to get the patent. That’s a lifetime in the fashion industry, where the lifespan of an article of clothing is a season, if you’re lucky.”
Lululemon, which has more than three dozen design patents, “clearly sees this bra as a product that’s going to have a long shelf life,” Ganoza added.
Ganoza explained that these kinds of lawsuits are rare in the fashion industry as few retailers are willing to go through the trouble — or expense — of securing design patents for their products. She also explained that “this is a long, expensive process — we’re talking at least a year and half, and several thousand dollars — just to get the patent. That’s a lifetime in the fashion industry, where the lifespan of an article of clothing is a season, if you’re lucky.”
Lululemon, which has more than three dozen design patents, “clearly sees this bra as a product that’s going to have a long shelf life,” Ganoza added.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”